论文部分内容阅读
本文就京都大学有关酮替芬糖浆对小儿支气管哮喘的有效性、实用性、安全性及对患儿生活能力的改善加以讨论。对象与方法以1987年11月至1988年5月,包括京都大学医学部附属医院儿科等16个单位确诊的小儿支气管哮喘病人为对象。不管年龄、性别、住院或门诊的病人,不管病型及严重度,但合并急、慢性呼吸道感染、肺气肿、支气管扩张等和药效判定困难的小儿,有心、肝、肾和其他严重合并症者除外。试验所用的1g酮替芬糖浆中含酮替芬1mg。于早餐后和就寝前(晚饭后也可)每日2次口服。6个月～3岁用0.4g×2,3～7岁用0.6g×2,7岁以上用1.0g×2,分2次口服。治疗8～12周。禁止并用
This article discusses the effectiveness, utility and safety of ketotifen syrup for children with bronchial asthma and the improvement of children’s living ability. Subjects and methods In November 1987 to May 1988, including Kyoto University Hospital, Pediatrics and other 16 units diagnosed pediatric bronchial asthma patients as the object. Regardless of age, sex, hospital or outpatient patients, regardless of type and severity, but with acute and chronic respiratory infections, emphysema, bronchiectasis and efficacy of children difficult to determine, with heart, liver, kidney and other serious complications Except the disease. 1 g of ketotifen syrup used in the test contained ketotifen 1 mg. After breakfast and before going to bed (also after dinner) 2 times a day orally. 6 months to 3 years old with 0.4g × 2,3 to 7 years old with 0.6g × 2, 7 years old with 1.0g × 2, 2 times orally. Treatment of 8 to 12 weeks. Prohibit and use